The Latin America, Middle East and Africa Penicillin Drug Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030).
Companies are investing significantly in developing alternative formulations with benefits like enhanced pharmacokinetics or increased patient tolerance of penicillin drugs. In particular, the finished dosage form of penicillin, regarded as the most popular class of antibiotics, is targeted to satisfy the rising global demand for the necessary antibiotics.
According to the International Trade Administration, Brazil is the largest healthcare market in Latin America and spends 9.1% of its GDP on healthcare. 63% of the 6,642 hospitals in Brazil are private. 532,645 hospital beds, 88,000 healthcare support services, 502,000 doctors, 331,000 dentists, and89,000 pharmacies are all present as of 2021. Brazil is one of the top six industries in the world for pharmaceuticals and drugs. $16.37 billion was spent on sales in 2021, an increase of 14.26% from 2020 (IQVA). Sales are anticipated to reach $20 billion in 2022. Brazilian imports of pharmaceuticals and raw materials totalled $7.06 billion in 2020. Europe is Brazil’s primary exporter of high-value- added pharmaceuticals. 14% of all Brazilian drug imports come from the United States.
The Saudi Arabian government intends to invest more than $65 billion to build the nation’s healthcare infrastructure as part of Vision 2030, according to the International Trade Administration. Additionally, it wants to privatize 290 hospitals and 2,300 primary health centers by 2030, increasing private sector participation from 40% to 65%. The Saudi Arabian dental care services industry is expected to expand due to rising per capita income, insurance coverage penetration, and dental care spending. There is a high need for dental care, and access to preventive and aesthetic dental care has improved. It is projected that the market will expand as a result of expanding dental care and healthcare infrastructure.
The Brazil market dominated the LAMEA Penicillin Drug Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $211.9 million by 2030. The Argentina market is estimated to witness a CAGR of 6.8% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 5.9% during (2023 - 2030).
Based on Source, the market is segmented into Semisynthetic Penicillin and Natural Penicillin. Based on Spectrum of Activity, the market is segmented into Broad spectrum, Extended spectrum and Narrow spectrum. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Penicillin Drug Market is Projected to reach USD 10.9 Billion by 2030, at a CAGR of 3.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Novartis AG, Lupin Limited, Abbott Laboratories, Cipla Limited, Takeda Pharmaceutical Company Limited, Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Source
- Semisynthetic Penicillin
- Natural Penicillin
By Spectrum of Activity
- Broad spectrum
- Extended spectrum
- Narrow spectrum
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Route of Administration
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Novartis AG
- Lupin Limited
- Abbott Laboratories
- Cipla Limited
- Takeda Pharmaceutical Company Limited
- Alkem Laboratories Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Penicillin Drug Market, by Source
1.4.2 LAMEA Penicillin Drug Market, by Spectrum of Activity
1.4.3 LAMEA Penicillin Drug Market, by Distribution Channel
1.4.4 LAMEA Penicillin Drug Market, by Route of Administration
1.4.5 LAMEA Penicillin Drug Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. LAMEA Penicillin Drug Market by Source
5.1 LAMEA Semisynthetic Penicillin Market by Country
5.2 LAMEA Natural Penicillin Market by Country
Chapter 6. LAMEA Penicillin Drug Market by Spectrum of Activity
6.1 LAMEA Broad spectrum Market by Country
6.2 LAMEA Extended spectrum Market by Country
6.3 LAMEA Narrow spectrum Market by Country
Chapter 7. LAMEA Penicillin Drug Market by Distribution Channel
7.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
7.2 LAMEA Hospital Pharmacies Market by Country
7.3 LAMEA Online Providers Market by Country
Chapter 8. LAMEA Penicillin Drug Market by Route of Administration
8.1 LAMEA Parenteral Market by Country
8.2 LAMEA Oral Market by Country
Chapter 9. LAMEA Penicillin Drug Market by Country
9.1 Brazil Penicillin Drug Market
9.1.1 Brazil Penicillin Drug Market by Source
9.1.2 Brazil Penicillin Drug Market by Spectrum of Activity
9.1.3 Brazil Penicillin Drug Market by Distribution Channel
9.1.4 Brazil Penicillin Drug Market by Route of Administration
9.2 Argentina Penicillin Drug Market
9.2.1 Argentina Penicillin Drug Market by Source
9.2.2 Argentina Penicillin Drug Market by Spectrum of Activity
9.2.3 Argentina Penicillin Drug Market by Distribution Channel
9.2.4 Argentina Penicillin Drug Market by Route of Administration
9.3 UAE Penicillin Drug Market
9.3.1 UAE Penicillin Drug Market by Source
9.3.2 UAE Penicillin Drug Market by Spectrum of Activity
9.3.3 UAE Penicillin Drug Market by Distribution Channel
9.3.4 UAE Penicillin Drug Market by Route of Administration
9.4 Saudi Arabia Penicillin Drug Market
9.4.1 Saudi Arabia Penicillin Drug Market by Source
9.4.2 Saudi Arabia Penicillin Drug Market by Spectrum of Activity
9.4.3 Saudi Arabia Penicillin Drug Market by Distribution Channel
9.4.4 Saudi Arabia Penicillin Drug Market by Route of Administration
9.5 South Africa Penicillin Drug Market
9.5.1 South Africa Penicillin Drug Market by Source
9.5.2 South Africa Penicillin Drug Market by Spectrum of Activity
9.5.3 South Africa Penicillin Drug Market by Distribution Channel
9.5.4 South Africa Penicillin Drug Market by Route of Administration
9.6 Nigeria Penicillin Drug Market
9.6.1 Nigeria Penicillin Drug Market by Source
9.6.2 Nigeria Penicillin Drug Market by Spectrum of Activity
9.6.3 Nigeria Penicillin Drug Market by Distribution Channel
9.6.4 Nigeria Penicillin Drug Market by Route of Administration
9.7 Rest of LAMEA Penicillin Drug Market
9.7.1 Rest of LAMEA Penicillin Drug Market by Source
9.7.2 Rest of LAMEA Penicillin Drug Market by Spectrum of Activity
9.7.3 Rest of LAMEA Penicillin Drug Market by Distribution Channel
9.7.4 Rest of LAMEA Penicillin Drug Market by Route of Administration
Chapter 10. Company Profiles
10.1 Novartis AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Teva Pharmaceutical Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Sun Pharmaceutical Industries Ltd.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 GlaxoSmithKline PLC (GSK)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional & Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.5.3 Trials and Approvals:
10.5.6 SWOT Analysis
10.6 Lupin Limited
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Recent strategies and developments:
10.6.3.1 Partnerships, Collaborations, and Agreements:
10.6.4 SWOT Analysis
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 Cipla Limited
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Acquisition and Mergers:
10.8.6 SWOT Analysis
10.9 Alkem Laboratories Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Product Launches and Product Expansions:
10.9.6 SWOT Analysis
10.10. Takeda Pharmaceutical Company Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Acquisition and Mergers:
10.10.6 SWOT Analysis
TABLE 1 LAMEA Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Penicillin Drug Market
TABLE 4 Product Launches And Product Expansions– Penicillin Drug Market
TABLE 5 Acquisition and Mergers– Penicillin Drug Market
TABLE 6 Trials and Approvals- Penicillin Drug Market
TABLE 7 LAMEA Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 8 LAMEA Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 9 LAMEA Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Natural Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Natural Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 14 LAMEA Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 15 LAMEA Broad spectrum Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Broad spectrum Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Extended spectrum Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Extended spectrum Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Narrow spectrum Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Narrow spectrum Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 LAMEA Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 23 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 30 LAMEA Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 31 LAMEA Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Parenteral Market by Country, 2023 - 2030, USD Million
TABLE 33 LAMEA Oral Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Oral Market by Country, 2023 - 2030, USD Million
TABLE 35 LAMEA Penicillin Drug Market by Country, 2019 - 2022, USD Million
TABLE 36 LAMEA Penicillin Drug Market by Country, 2023 - 2030, USD Million
TABLE 37 Brazil Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 38 Brazil Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 39 Brazil Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 40 Brazil Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 41 Brazil Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 42 Brazil Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 43 Brazil Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Brazil Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 45 Brazil Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 Brazil Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 47 Argentina Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 48 Argentina Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 49 Argentina Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 50 Argentina Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 51 Argentina Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 52 Argentina Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 53 Argentina Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 Argentina Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 Argentina Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Argentina Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 UAE Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 58 UAE Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 59 UAE Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 60 UAE Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 61 UAE Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 62 UAE Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 63 UAE Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 UAE Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 UAE Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 UAE Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 67 Saudi Arabia Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 68 Saudi Arabia Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 69 Saudi Arabia Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 70 Saudi Arabia Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 71 Saudi Arabia Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 72 Saudi Arabia Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 73 Saudi Arabia Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Saudi Arabia Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Saudi Arabia Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 76 Saudi Arabia Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 77 South Africa Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 78 South Africa Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 79 South Africa Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 80 South Africa Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 81 South Africa Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 82 South Africa Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 83 South Africa Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 South Africa Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 South Africa Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 South Africa Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 Nigeria Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 88 Nigeria Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 89 Nigeria Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 90 Nigeria Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 91 Nigeria Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 92 Nigeria Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 93 Nigeria Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 94 Nigeria Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 95 Nigeria Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 96 Nigeria Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 97 Rest of LAMEA Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 98 Rest of LAMEA Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 99 Rest of LAMEA Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 100 Rest of LAMEA Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 101 Rest of LAMEA Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 102 Rest of LAMEA Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 103 Rest of LAMEA Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 104 Rest of LAMEA Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 105 Rest of LAMEA Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 106 Rest of LAMEA Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 107 Key Information – Novartis AG
TABLE 108 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 109 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 110 Key Information – GlaxoSmithKline PLC
TABLE 111 Key Information – Pfizer, Inc.
TABLE 112 Key Information – Lupin Limited
TABLE 113 Key Information – Abbott Laboratories
TABLE 114 Key Information – Cipla Limited
TABLE 115 Key Information – Alkem Laboratories Ltd.
TABLE 116 Key Information – Takeda Pharmaceutical Company Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Penicillin Drug Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Penicillin Drug Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
FIG 7 Porter’s Five Forces Analysis – Penicillin Drug Market
FIG 8 LAMEA Penicillin Drug Market share by Source, 2022
FIG 9 LAMEA Penicillin Drug Market share by Source, 2030
FIG 10 LAMEA Penicillin Drug Market by Source, 2019 - 2030, USD Million
FIG 11 LAMEA Penicillin Drug Market share by Spectrum of Activity, 2022
FIG 12 LAMEA Penicillin Drug Market share by Spectrum of Activity, 2030
FIG 13 LAMEA Penicillin Drug Market by Spectrum of Activity, 2019 - 2030, USD Million
FIG 14 LAMEA Penicillin Drug Market share by Distribution Channel, 2022
FIG 15 LAMEA Penicillin Drug Market share by Distribution Channel, 2030
FIG 16 LAMEA Penicillin Drug Market by Distribution Channel, 2019 - 2030, USD Million
FIG 17 LAMEA Penicillin Drug Market share by Route of Administration, 2022
FIG 18 LAMEA Penicillin Drug Market share by Route of Administration, 2030
FIG 19 LAMEA Penicillin Drug Market by Route of Administration, 2019 - 2030, USD Million
FIG 20 LAMEA Penicillin Drug Market share by Country, 2022
FIG 21 LAMEA Penicillin Drug Market share by Country, 2030
FIG 22 LAMEA Penicillin Drug Market by Country, 2019 - 2030, USD Million
FIG 23 SWOT Analysis: Novartis AG
FIG 24 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 26 SWOT Analysis: GlaxoSmithKline PLC
FIG 27 Recent strategies and developments: Pfizer, Inc.
FIG 28 SWOT Analysis: Pfizer, Inc.
FIG 29 SWOT Analysis: Lupin Limited
FIG 30 SWOT Analysis: Abbott Laboratories
FIG 31 SWOT Analysis: Cipla Limited
FIG 32 SWOT Analysis: Alkem Laboratories Ltd.
FIG 33 SWOT Analysis: Takeda Pharmaceutical Company Limited